ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D

Company

Neumora Therapeutics, Inc.

Filed

October 2, 2023

Accession Number

0001072613-23-000508

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →